Abstract
Tissue injury and inflammation result in release of various mediators that promote ongoing pain or pain hypersensitivity against mechanical, thermal and chemical stimuli. Pro-nociceptive mediators activate primary afferent neurons directly or indirectly to enhance nociceptive signal transmission to the central nervous system. Excitation of primary afferents by peripherally originating mediators, so-called “peripheral sensitization”, is a hallmark of tissue injuryrelated pain. Many kinds of pro-nociceptive mediators, including ATP, glutamate, kinins, cytokines and tropic factors, synthesized at the damaged tissue, contribute to the development of peripheral sensitization. In the present review we will discuss the molecular mechanisms of peripheral sensitization following tissue injury.
Keywords: Peripheral sensitization, postoperative pain, primary afferent neuron.
Current Neuropharmacology
Title:Tissue Injury and Related Mediators of Pain Exacerbation
Volume: 11 Issue: 6
Author(s): Fumimasa Amaya, Yuta Izumi, Megumi Matsuda and Mika Sasaki
Affiliation:
Keywords: Peripheral sensitization, postoperative pain, primary afferent neuron.
Abstract: Tissue injury and inflammation result in release of various mediators that promote ongoing pain or pain hypersensitivity against mechanical, thermal and chemical stimuli. Pro-nociceptive mediators activate primary afferent neurons directly or indirectly to enhance nociceptive signal transmission to the central nervous system. Excitation of primary afferents by peripherally originating mediators, so-called “peripheral sensitization”, is a hallmark of tissue injuryrelated pain. Many kinds of pro-nociceptive mediators, including ATP, glutamate, kinins, cytokines and tropic factors, synthesized at the damaged tissue, contribute to the development of peripheral sensitization. In the present review we will discuss the molecular mechanisms of peripheral sensitization following tissue injury.
Export Options
About this article
Cite this article as:
Amaya Fumimasa, Izumi Yuta, Matsuda Megumi and Sasaki Mika, Tissue Injury and Related Mediators of Pain Exacerbation, Current Neuropharmacology 2013; 11 (6) . https://dx.doi.org/10.2174/1570159X11311060003
DOI https://dx.doi.org/10.2174/1570159X11311060003 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Phase-Change Contrast Agents for Imaging and Therapy
Current Pharmaceutical Design Impact of Antiretroviral Therapy on the Relapse of Cryptococcosis and Survival of HIV-Infected Patients with Cryptococcal Infection
Current HIV Research Plasma Metabolome Signature in Patients with Early-stage Parkinson Disease
Current Metabolomics Inhalational Injury: A Brief Review of Pathophysiology, Diagnosis and Treatment
Current Respiratory Medicine Reviews The Genomic Approaches to Major Depression
Current Pharmacogenomics Classification of Human Pregnane X Receptor (hPXR) Activators and Non-Activators by Machine Learning Techniques: A Multifaceted Approach
Combinatorial Chemistry & High Throughput Screening Evaluation of in vivo Anti-inflammatory and Analgesic Activities of Novel Derivatives of Ugi-4CR
Mini-Reviews in Medicinal Chemistry Polymorphism in Endothelin-1 Gene: An Overview
Current Clinical Pharmacology Quadruplex-Forming Oligonucleotides as Tools in Anticancer Therapy and Aptamers Design: Energetic Aspects
Current Medicinal Chemistry - Anti-Cancer Agents The Neurokinins: Peptidomimetic Ligand Design and Therapeutic Applications
Current Medicinal Chemistry Role of Gap Junction Channel in the Development of Beat-to-Beat Action Potential Repolarization Variability and Arrhythmias
Current Pharmaceutical Design Catching the Therapeutic Window of Opportunity in Early Crohn`s Disease
Current Drug Targets Copper Binding Extrinsic to the Octarepeat Region in the Prion Protein
Current Protein & Peptide Science Progress in Nutritional and Health Profile of Milk and Dairy Products: A Novel Drug Target
Endocrine, Metabolic & Immune Disorders - Drug Targets Human β-secretase (BACE) and BACE Inhibitors: Progress Report
Current Topics in Medicinal Chemistry Astrocytic Expression of the Immunoreceptor CD300f Protects Hippocampal Neurons from Amyloid-β Oligomer Toxicity In Vitro
Current Alzheimer Research Schwann Cell Transplantation for CNS Repair
Current Medicinal Chemistry Ketamine-Induced Neurotoxicity and Changes in Gene Expression in the Developing Rat Brain
Current Neuropharmacology The Developing Role of Neuregulin1 In Cardiac Regenerative Stem Cell Therapy
Current Pharmaceutical Design Pindolol Augmentation of Antidepressant Response
Current Drug Targets